SEC Tracker
Get the app
Person · CIK 1488864

Ira Duarte

EVP at Heron Therapeutics; director at TerrAscend

Earlier: Cornerstone Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$76K
Companies3

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Heron Therapeutics HRTXCommon StockDirectly284,671Oct 19, 2026 · Filing · EDGAR
Heron Therapeutics HRTXRestricted Stock Units
into Common Stock
Directly19,372Oct 19, 2026 · Filing · EDGAR
TerrAscend TRSSFCommon SharesDirectly657,930Jun 24, 2025 · Filing · EDGAR

Sold and noticed by quarter

Ira Duarte: dollars sold on Form 4 and noticed on Form 144 per quarter, Q4 2023 to Q4 2026$76K$0Q4 2023: $0 noticed on Form 144Q4 2023: $0 sold on Form 4Q4 2023: $76K boughtQ1 2024: $0 noticed on Form 144Q1 2024: $0 sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q4 2023Q3 2024Q2 2025Q1 2026Q4 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)Bought (Form 4)
Q4 2023——$76K

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Heron Therapeutics HRTX EVP, Chief Financial Officer · filings 2023 to 2026 · bought $76K

DateTransactionSharesPriceValueHeld afterSource
Oct 19, 2026Option or RSU exercised or converted+3,874285,773 directFiling · EDGAR
Oct 19, 2026Shares withheld for tax or exercise price−1,102$0.36$397284,671 directFiling · EDGAR
Oct 19, 2026Option or RSU exercised or converted
Restricted Stock Units
−3,87419,372 directFiling · EDGAR
Jul 31, 2026Option or RSU exercised or converted+11,694285,225 directFiling · EDGAR
Jul 31, 2026Shares withheld for tax or exercise price−3,326$0.50$2K281,899 directFiling · EDGAR
Jul 31, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,694116,944 directFiling · EDGAR
Jul 30, 2026Option or RSU exercised or converted+13,535277,381 directFiling · EDGAR
Jul 30, 2026Shares withheld for tax or exercise price−3,850$0.50$2K273,531 directFiling · EDGAR
Jul 30, 2026Option or RSU exercised or converted
Restricted Stock Units
−13,535189,492 directFiling · EDGAR
Jul 19, 2026Option or RSU exercised or converted+3,874264,947 directFiling · EDGAR
Jul 19, 2026Shares withheld for tax or exercise price−1,101$0.47$517263,846 directFiling · EDGAR
Jul 19, 2026Option or RSU exercised or converted
Restricted Stock Units
−3,87423,246 directFiling · EDGAR
Jun 16, 2026Option or RSU exercised or converted+12,500264,628 directFiling · EDGAR
Jun 16, 2026Shares withheld for tax or exercise price−3,555$0.38$1K261,073 directFiling · EDGAR
Jun 16, 2026Option or RSU exercised or converted
Restricted Stock Units
−12,50012,500 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted+11,694227,570 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted+13,535252,128 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,694128,638 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted
Restricted Stock Units
−13,535203,027 directFiling · EDGAR
Apr 19, 2026Option or RSU exercised or converted+3,874215,876 directFiling · EDGAR
Apr 19, 2026Option or RSU exercised or converted
Restricted Stock Units
−3,87427,120 directFiling · EDGAR
Jan 31, 2026Option or RSU exercised or converted+11,695195,356 directFiling · EDGAR
Jan 31, 2026Option or RSU exercised or converted
Restricted Stock Units
−11,695140,332 directFiling · EDGAR
Jan 30, 2026Grant or award from the company
Restricted Stock Units
+216,562216,562 directFiling · EDGAR
Jan 30, 2026Grant or award from the company
Performance Stock Units
+216,561216,561 directFiling · EDGAR
Jan 19, 2026Option or RSU exercised or converted+3,875183,661 directFiling · EDGAR
Jan 19, 2026Option or RSU exercised or converted
Restricted Stock Units
−3,87530,994 directFiling · EDGAR
Oct 31, 2025Option or RSU exercised or converted+11,694179,786 directFiling · EDGAR
Oct 31, 2025Option or RSU exercised or converted
Restricted Stock Units
−11,694152,027 directFiling · EDGAR
Oct 19, 2025Option or RSU exercised or converted+3,874168,092 directFiling · EDGAR
Oct 19, 2025Option or RSU exercised or converted
Restricted Stock Units
−3,87434,869 directFiling · EDGAR
Jul 31, 2025Option or RSU exercised or converted+11,695164,218 directFiling · EDGAR
Jul 31, 2025Option or RSU exercised or converted
Restricted Stock Units
−11,695163,721 directFiling · EDGAR
Jul 19, 2025Option or RSU exercised or converted+3,874152,523 directFiling · EDGAR
Jul 19, 2025Option or RSU exercised or converted
Restricted Stock Units
−3,87438,743 directFiling · EDGAR
Jun 16, 2025Option or RSU exercised or converted+12,500148,649 directFiling · EDGAR
Jun 16, 2025Option or RSU exercised or converted
Restricted Stock Units
+12,50025,000 directFiling · EDGAR
Apr 30, 2025Option or RSU exercised or converted+11,694136,149 directFiling · EDGAR
Apr 30, 2025Option or RSU exercised or converted
Restricted Stock Units
+11,694175,416 directFiling · EDGAR
Apr 19, 2025Option or RSU exercised or converted+3,875124,455 directFiling · EDGAR
Apr 19, 2025Option or RSU exercised or converted
Restricted Stock Units
+3,87542,617 directFiling · EDGAR
Jan 31, 2025Grant or award from the company
Employee Stock Option (Right to Buy)
+374,220374,220 directFiling · EDGAR
Jan 31, 2025Grant or award from the company
Restricted Stock Units
+187,110187,110 directFiling · EDGAR
Jan 19, 2025Option or RSU exercised or converted+3,874120,580 directFiling · EDGAR
Jan 19, 2025Option or RSU exercised or converted
Restricted Stock Units
−3,87446,492 directFiling · EDGAR
Oct 19, 2024Option or RSU exercised or converted+3,874108,001 directFiling · EDGAR
Oct 19, 2024Option or RSU exercised or converted
Restricted Stock Units
−3,87450,366 directFiling · EDGAR
Jul 19, 2024Option or RSU exercised or converted+3,875104,127 directFiling · EDGAR
Jul 19, 2024Option or RSU exercised or converted
Restricted Stock Units
−3,87554,240 directFiling · EDGAR
Jun 16, 2024Option or RSU exercised or converted+12,500100,252 directFiling · EDGAR
Jun 16, 2024Option or RSU exercised or converted
Restricted Stock Units
−12,50037,500 directFiling · EDGAR
Apr 19, 2024Option or RSU exercised or converted+3,87488,874 directFiling · EDGAR
Apr 19, 2024Shares withheld for tax or exercise price−1,122$2.64$3K87,752 directFiling · EDGAR
Apr 19, 2024Option or RSU exercised or converted
Restricted Stock Units
−3,87458,115 directFiling · EDGAR
Jan 19, 2024Grant or award from the company
Employee Stock Option (Right to Buy)
+371,935371,935 directFiling · EDGAR
Jan 19, 2024Grant or award from the company
Restricted Stock Units
+61,98961,989 directFiling · EDGAR
Nov 16, 2023Open-market or private purchase+85,000$0.89$76K85,000 directFiling · EDGAR

TerrAscend TRSSF Director · filings 2022 to 2025

DateTransactionSharesPriceValueHeld afterSource
Jun 24, 2025Grant or award from the company+433,653657,930 directFiling · EDGAR
Dec 31, 2024Shares withheld for tax or exercise price−71,704$0.65$47K224,277 directFiling · EDGAR
Jun 17, 2024Grant or award from the company+163,334295,981 directFiling · EDGAR
Jun 22, 2023Grant or award from the company+132,647132,647 directFiling · EDGAR

Cornerstone Therapeutics Principal Accounting Officer · filings 2010 to 2014

DateTransactionSharesPriceValueHeld afterSource
Feb 3, 2014Returned to the company−7,000$9.50$67K0 directFiling · EDGAR
Feb 3, 2014Returned to the company
Option to Purchase Common Stock (Right to Buy)
−20,000$2.22$44K0 directFiling · EDGAR
Feb 3, 2014Returned to the company
Option to Purchase Common Stock (Right to Buy)
−8,000$4.24$34K0 directFiling · EDGAR
Feb 3, 2014Returned to the company
Option to Purchase Common Stock (Right to Buy)
−20,000$4.25$85K0 directFiling · EDGAR
Feb 3, 2014Returned to the company
Option to Purchase Common Stock (Right to Buy)
−7,500$3.76$28K0 directFiling · EDGAR
Mar 7, 2013Grant or award from the company+7,0007,000 directFiling · EDGAR
Feb 29, 2012Grant or award from the company
Option to Purchase Common Stock (Right to Buy)
+7,5007,500 directFiling · EDGAR
Mar 2, 2011Grant or award from the company
Option to Purchase Common Stock (Right to Buy)
+20,00020,000 directFiling · EDGAR
All 35 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 21, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Aug 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Jul 20, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Jun 17, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
May 4, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Apr 21, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Feb 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Feb 3, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Jan 20, 2026Form 4Heron Therapeutics HRTXFiling · EDGAR
Nov 4, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Oct 21, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Aug 4, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Jul 22, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Jun 25, 2025Form 4TerrAscend TRSSFFiling · EDGAR
Jun 17, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
May 2, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Apr 22, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Feb 4, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Jan 22, 2025Form 4Heron Therapeutics HRTXFiling · EDGAR
Jan 3, 2025Form 4TerrAscend TRSSFFiling · EDGAR
Oct 21, 2024Form 4Heron Therapeutics HRTXFiling · EDGAR
Jul 22, 2024Form 4Heron Therapeutics HRTXFiling · EDGAR
Jun 20, 2024Form 4TerrAscend TRSSFFiling · EDGAR
Jun 17, 2024Form 4Heron Therapeutics HRTXFiling · EDGAR
Apr 19, 2024Form 4Heron Therapeutics HRTXFiling · EDGAR
Jan 19, 2024Form 4Heron Therapeutics HRTXFiling · EDGAR
Nov 17, 2023Form 4Heron Therapeutics HRTXFiling · EDGAR
Jun 26, 2023Form 4TerrAscend TRSSFFiling · EDGAR
Jun 23, 2023Form 3Heron Therapeutics HRTXFiling · EDGAR
Dec 9, 2022Form 3TerrAscend TRSSFFiling · EDGAR
Feb 4, 2014Form 4Cornerstone TherapeuticsFiling · EDGAR
Mar 11, 2013Form 4Cornerstone TherapeuticsFiling · EDGAR
Apr 3, 2012Form 4Cornerstone TherapeuticsFiling · EDGAR
Mar 4, 2011Form 4Cornerstone TherapeuticsFiling · EDGAR
Apr 8, 2010Form 3Cornerstone TherapeuticsFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.